由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
_pennystock版 - PRAN +85%
相关主题
MDVN Adam觉得2010 bio的重头戏2011 BIO CEO & Investor Conference
MDVN!10 Biotech Trades for Second Half of 2011
***********2/08-2/12 选股大赛**************dndn 3Q
下周生拉关注/持有名单, 请大/专家发表意见癌症药大会马上就来了,大家看好了哦
MDVNMDVN approval
准备抄 MDVNRNN壮观啊
HGSI FDA meeting (转载)IDIX KID
Stocks to Watch at JPMorgan Healthcare Conference【技术贴】IDIX
相关话题的讨论汇总
话题: pbt2话题: alzheimer话题: disease话题: prana话题: patients
1 (共1页)
t*******o
发帖数: 1464
1
Prana Biotechnology Limited Announces Publication Of New Analysis In Journal
Of Alzheimer's Disease
11:10am EDT
Prana Biotechnology Limited announced that the Journal of Alzheimer's
Disease, published an article on April 19 about Prana's lead drug candidate
for Alzheimer's disease, PBT2, providing new analysis that it is effective
in reversing dementia symptoms. The analysis, conducted by Professor Ashley
Bush of The Mental Health Research Institute and The University of Melbourne
, Australia, is based on tracking and ranking the responses of each
individual patient, rather than only groups of patients, in Prana's PBT2's
Phase IIa Alzheimer's disease clinical trial. The results of the Phase IIa
clinical trial, previously reported in The Lancet Neurology (July 2008 and
an erratum in July 2009), showed that patients with mild Alzheimer's Disease
treated with 250mg of PBT2, experienced an overall statistically
significant improvement in Executive Function on a Neuropsychological Test
Battery (NTB) within 12 weeks of treatment. The objective of the analysis
was to see how individual patients who were receiving PBT2 responded
compared to the individual patients who only received placebo. This new
analysis has adjusted for this and demonstrated that: 81% of patients on the
250mg dose of PBT2 responded better on the Executive Factor NTB score than
the performing patient on placebo. 41% of patients on the 250mg dose of PBT2
responded better on the overall Composite NTB score than the performing
patient on placebo.
c*****j
发帖数: 92
2
收在高点,要不要钓一点等明天?
c********g
发帖数: 1106
3
这个值得长期跟踪。最后能成药的话,翻几十倍都有可能。当然也可能血本无归。

【在 c*****j 的大作中提到】
: 收在高点,要不要钓一点等明天?
c*****j
发帖数: 92
4
概率多大,帮忙科普一下,谢谢
t*******o
发帖数: 1464
5
Journal of Alzheimer's Disease 这杂志靠普吗?
我上次就是死在MDVN的Alzheimer上了
c*****j
发帖数: 92
6
贴张pipeline图
c*****j
发帖数: 92
7
Ten-Bagger Chase Goes After Prana (PRAN)
April 19, 2010 · Filed Under Financial, alzheimer's
Prana Biotechnology Ltd. (NASDAQ: PRAN) is up over 100% today on some
published data. The share trading activity is indicative of traders and
investors looking for the next biotech ten-bagger, or that search for a 1,
000% Gainer.
The report causing the run-up is new published analysis of its clinical
trial excerpt taken from the Journal of Alzheimer’s Disease.
The publication published an article about Prana’s lead drug candidate
dubbed PBT2 for Alzheimer’s Disease. New analysis shows that PBT2 is
effective in reversing dementia symptoms. To date, all market-approved
Alzheimer’s and dementia drugs are aimed to slow the progression of the
disease.
The results of the Phase IIa clinical trial, which were previously reported
in The Lancet Neurology in July 2008, showed that patients with mild
Alzheimer’s Disease treated with 250mg of PBT2 experienced an overall
statistically significant improvement in executive function on a
neuropsychological test battery within 12 weeks of treatment.
The new analysis has adjusted for the prior data and showed that 81% of
patients on the 250mg dose of PBT2 responded better on the executive factor
NTB score than the best performing patient on placebo. The data also noted
that some 41% of patients on the 250mg dose of PBT2 responded better on the
overall composite NTB score than the best performing patient on placebo.
Delaying and minimizing effects of Alzheimer’s, dementia, and other memory-
loss diseases is one thing. Reversing the effects after damage has already
begun, that is something different entirely.
In mid-day trading, this stock is up 105% at $2.77 on over million shares.
At one point the stock was up as high as $3.35, but either way the first
move and second move indicate that this may be a 52-week high close. Its
old 52-week trading range was $1.02 to $2.17 before today, so even if this
drops back lower the new 52-week highs have been put in.
We have also seen over 4 million shares trade hands, so its 35,000 or so
average daily volume has been passed 100-times over. And then some.
After going through the Prana history, this has spent some time as a $5.00
stock and has even tried to get closer to $10.00 before gravity pulled it
back down.
JON C. OGG
t*******o
发帖数: 1464
8
简单说就是,用老的数据,发表了一篇新的文章。
有没有说三期啥时候开始?

【在 c*****j 的大作中提到】
: Ten-Bagger Chase Goes After Prana (PRAN)
: April 19, 2010 · Filed Under Financial, alzheimer's
: Prana Biotechnology Ltd. (NASDAQ: PRAN) is up over 100% today on some
: published data. The share trading activity is indicative of traders and
: investors looking for the next biotech ten-bagger, or that search for a 1,
: 000% Gainer.
: The report causing the run-up is new published analysis of its clinical
: trial excerpt taken from the Journal of Alzheimer’s Disease.
: The publication published an article about Prana’s lead drug candidate
: dubbed PBT2 for Alzheimer’s Disease. New analysis shows that PBT2 is

c*****j
发帖数: 92
9
看起来PBT2很牛啊,PBT2 is effective in reversing dementia symptoms. To date
, all market-approved
Alzheimer’s and dementia drugs are aimed to slow the progression of the
disease.
c*****j
发帖数: 92
10
新文章的新内容在于量化了效果的百分比
This new analysis has adjusted for this and demonstrated that: 81% of
patients on the 250mg dose of PBT2 responded better on the Executive Factor
NTB score than the performing patient on placebo. 41% of patients on the
250mg dose of PBT2 responded better on the overall Composite NTB score than
the performing patient on placebo.

【在 t*******o 的大作中提到】
: 简单说就是,用老的数据,发表了一篇新的文章。
: 有没有说三期啥时候开始?

1 (共1页)
相关主题
【技术贴】IDIXMDVN
2011 biotech 系列(1)--XNPT准备抄 MDVN
AEN看的一头雾水阿HGSI FDA meeting (转载)
AVEO,关注一下Stocks to Watch at JPMorgan Healthcare Conference
MDVN Adam觉得2010 bio的重头戏2011 BIO CEO & Investor Conference
MDVN!10 Biotech Trades for Second Half of 2011
***********2/08-2/12 选股大赛**************dndn 3Q
下周生拉关注/持有名单, 请大/专家发表意见癌症药大会马上就来了,大家看好了哦
相关话题的讨论汇总
话题: pbt2话题: alzheimer话题: disease话题: prana话题: patients